-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
EURBörse Börse Frankfurt-
EUROcugen IncBörse Börse Frankfurt
-
EUROcugen IncBörse Börse Berlin
-
OCUGEN INCBörse Börse HamburgEURSymbol 2H51
-
OCUGEN INCBörse Gettex System der Börse MünchenEURSymbol 2H51
-
OCUGEN INCBörse Quotrix System der Börse DüsseldorfEURSymbol 2H51
-
OCUGEN INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 2H51
-
Ocugen IncBörse NasdaqISIN US67577C1053 WKN: A2PSZHUSDSymbol OCGN
-
ISIN US67577C1053 WKN: A2PSZHUSDSymbol OCGN
-
MXN
-
Firmenname
Ocugen, IncCEO: Shankar Musunuri
Marktkapitalisierung
2.426.421.568 (+- 21%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.922.843.136 oder 2.930.000.000
Mitarbeiter
38 (+- 119%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
16 oder 15 oder 84 Mitarbeiter
KGV
0.08
EBITDA -15.215.256
PEGRatio None
Buchwert None
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 2,23 USD +2,34%
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
104 News & Informationen zur Ocugen Inc Aktie
Why Ocugen Is Rallying Today
Finally, a bit of good news for this oversold biotech.
Ocugen Q2 R&D expenses surged driven by licensing cost for Covaxin in Canada (NASDAQ:OCGN)
Ocugen (OCGN) reports financial results for Q2 ended June 30, 2021.The company did not record any revenue for the quarter ended June 30.R&D expenses were $18.9M, including a $15M…
Ocugen Provides Business Update and Second Quarter 2021 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET Rolling regulatory submission to Health Canada completed and review process initiated; U.S. FDA talks continueMultiple milestones achieved across regulatory and supply chain to support potential commercialization of pipeline assetsThe Company experienced organizational growth to reflect new business requirements in clinical development, manufacturing, and commercialization MALVERN, Pa., Aug. 06, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell
• Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of …
2 Ultra-Risky Stocks I Wouldn't Buy With Free Money
Even if you aren't risk-averse, you should think long and hard about holding these stocks.
3 Things About Moderna That Smart Investors Know
Add them up and you get a revolutionary company that's priced for perfection.
New Stocks to Watch at Investor Ideas in Cleantech (Nasdaq: ENVX), Mining (Nasdaq: OMEX), Tech (Nasdaq: OSS, Nasdaq: OBLG) and Biotech (Nasdaq: OCGN)
Current Most Shorted Stocks 2021
Why Ocugen Stock Rose, Then Slipped Today
An analyst launched coverage of the stock with an extremely bullish note, however…
Covaxin stares at an uncertain launch in US amid a class-action lawsuit
Two months before Ocugen, the US partner of Bharat Biotech International Ltd, announced its partnership with the company for bringing the covid-19 vaccine to the US, it was facing the threat of its shares being delisted from Nasdaq
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
BENSALEM, Pa., July 23, 2021 /PRNewswire/ — Law Offices of Howard G. Smith reminds investors of the upcoming August 16, 2021 deadline to file a lead plaintiff motion in the case filed on… | July 23, 2021
3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120%
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, July 21, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
54 Biggest Movers From Yesterday
Gainers Aehr Test Systems (NASDAQ:AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase o…
Hedge Funds Are Betting On Enova International Inc (ENVA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first…
Why Shares of Ocugen Climbed Today
The delta variant is lifting the tide of companies associated with COVID testing and prevention.
The daily dose: July 17, 2021
We curate for you all the Covid-19-related developments and stories of the day worth reading
Ocugen : Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. and Certain Officers – OCGN
NEW YORK, July 16, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. and certain of its officers. The class action, filed in… | July 17, 2021
Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. and Certain Officers – OCGN
/PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN) and certain…
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., July 16, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. OCGN, a biopharmaceutical company focused on discovering, developing, and commercializing gene
Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults
Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday.
Ocugen, Inc. annonce le lancement d’une présentation en continu à Santé Canada pour COVAXIN(MC)
MALVERN, Pennsylvanie, 15 juill. 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ : OCGN), une société biopharmaceutique axée sur la découverte, le…
DEADLINE ALERT for PRVB, WPG, SPCE, OCGN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
BENSALEM, Pa., July 15, 2021 — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…